Vijay Kuchroo

Vijay Kumar Kuchroo is the founder of Celsius Therapeutics, Inc., founded in 2018.
Dr. Kuchroo is also the founder of CoStim Pharmaceuticals, Inc.,Tempero Pharmaceuticals, Inc.,Larkspur Biosciences, Inc.,Tizona Therapeutics, Inc. Dr. Kuchroo is Director at Massachusetts Institute of Technology.
Dr. Kuchroo is Director at Evergrande Centre For Immunologic Diseases.
Dr. Kuchroo is Co-Director-Infection & Immunity at Brigham Research Institute.
Dr. Kuchroo is Founding Director at Mass General Hospital.
Dr. Kuchroo is Member- Scientific Advisory Board at Potenza Therapeutics, Inc. Dr. Kuchroo is Member at The Broad Institute, Inc. Dr. Kuchroo is Professor at Harvard Medical School.
Dr. Kuchroo is Venture Partner at Catalio Capital Management LP.
Dr. Kuchroo was Independent Non-Executive Director at Biocon Ltd. from 2015 to 2023.
Dr. Kuchroo was Independent Non-Executive Director at Syngene International Ltd. Dr. Kuchroo was Independent Director at Bicara Therapeutics, Inc. Dr. Kuchroo was Senior Scientist at The Brigham & Women's Hospital, Inc. Dr. Kuchroo earned a doctorate degree from The University of Queensland in 1985.
Dr. Kuchroo earned an undergraduate degree from Haryana Agricultural University in 1976.